Unlock instant, AI-driven research and patent intelligence for your innovation.

Nanomaterial composition, synthesis, and assembly

A composition and nanotube technology, which can be used in drug combination, drug delivery, organic active ingredients, etc., and can solve problems such as side effects and obstacles

Active Publication Date: 2021-05-04
RHODE ISLAND HOSPITAL
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the clinical use of these structures has been hampered by undesired or toxic side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nanomaterial composition, synthesis, and assembly
  • Nanomaterial composition, synthesis, and assembly
  • Nanomaterial composition, synthesis, and assembly

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0478] Preparation and application of nanometer material of the present invention

[0479] In particular embodiments, compounds of the invention may be used as nanocarriers for delivery of diagnostic or medical agents into cells. These compounds can be assembled into nanostructures, including nanotubes and / or nanosheets, which mimic or structurally mimic nucleic acid base pairs.

[0480] Provided herein is a method of making a nanotube-formulation complex. The method comprises combining a solution containing a compound of the invention with one or more agents (e.g., diagnostic or medical agents, e.g. siRNA, molecular beacons), wherein the compound self-assembles into nanotubes, and one or more agents Incorporation into nanotubes forms a nanotube-agent (population) complex whereby the agent (population) is delivered.

[0481] Alternatively, the method comprises combining a solution containing a compound of formula (I), (II), (III), (IV), (V), (VI), (VII), or (VIII) with one o...

example 1

[0577] Example 1: Compounds of the following formula:

[0578]

[0579] Wherein n is an integer from 1 to 6.

[0580] and R 1 For having an α or β-amino covalent bond (CH 2 ) n α or β-amino acids (in this case, amino acids refer to both D- and L-amino acids); or have terminal α or β-amino covalently bonded (CH 2 ) n carbon poly-alpha or beta-peptide. n is an integer starting from 0. The structures shown below are examples of some α or β-amino acids:

[0581]

[0582] R 1 The structure should also include the following structure:

[0583] and

[0584] In the above structure, j is an integer starting from 0, k is an integer starting from 0, m is an integer starting from 0, and p is an integer starting from 0; R x is aliphatic or hydrogen; R y is hydrogen or the following structure:

[0585] Among them, q, s and t are integers starting from 0.

[0586] and R 2 It is hydrogen, methyl, amino or the following structure:

[0587] where R z is aliphatic. ...

example 2

[0588] Example 2: Compounds of the following formula:

[0589]

[0590] Wherein n is an integer from 1 to 6.

[0591] and R 3 For having α or β-amino covalently bonded two (CH 2 ) n α or β-amino acids at the carbons of the linker (in this case amino acids refer to both D- and L-amino acids); or two (CH 2 ) n Poly-α or β-peptides of the carbons of the linker. The structures shown below are examples of some α or β-amino acids:

[0592]

[0593] R 3 The structure should also include the following structure:

[0594] and

[0595] In the above structure, k is an integer starting from 0, m is an integer starting from 0, and p is an integer starting from 0; R x is aliphatic or hydrogen; R y is hydrogen or the following structure:

[0596] Among them, q, s and t are integers starting from 0.

[0597] and R 4 It is hydrogen, methyl, amino or the following structure:

[0598] where R z is aliphatic.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The present invention relates to the composition or assembly of a series of simulated biological compounds, including chemical structures that simulate or structurally mimic nucleic acid base pairs. The complexes of nanotubes and formulations are suitable for delivery of formulations into cells or body tissues of individuals for medical and diagnostic purposes. Examples of compounds include those of formula (I), (III), (V) or (VII), or compounds of formula (II), (IV), (VI) or (VIII).

Description

[0001] Cross References to Related Applications [0002] This application claims priority and benefit to U.S. Provisional Application Serial No. 62 / 080,685, filed November 17, 2014, the entire contents of which are incorporated herein by reference. [0003] Description of government subsidies [0004] This invention was made with support from the National Institutes of Health under P20GM104937. The government has certain rights in the invention. technical field [0005] The present invention relates to a delivery agent of nanoparticles into cells or body tissues. Background technique [0006] Nanoparticles (eg, microscopic particles with at least one dimension less than 100 nanometers (nm)) have been used to transport molecules to cells and tissues. Various nanostructures, including liposomes, polymers, dendrimers, silicon or carbon materials, and magnetic nanoparticles, have been used as carriers in drug delivery systems. However, the clinical use of these structures ha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/535
CPCA61K45/06A61L2400/12A61F2/30756C07D519/00A61L27/227A61L27/50A61L27/54A61L2300/252A61L2300/406A61L2300/414A61K47/542A61K47/6925C07D487/04C07D471/04A61P17/00A61P17/02A61P19/08A61P43/00A61K31/519A61K47/545A61L27/20A61L27/52
Inventor 陈迁于洪川陈宇鹏
Owner RHODE ISLAND HOSPITAL